Remote assessment for people with Parkinson's
Part of Brain & nervous system clinical trials.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been formally diagnosed with Parkinson's disease.
- You do not have a GBA gene variant (a specific genetic form of Parkinson's will be asked to join a different study).
- You do not have another condition that causes parkinsonism, such as multiple system atrophy or progressive supranuclear palsy.
- You do not have another neurological disorder like dementia or motor neurone disease.
- You are not taking any medications that can cause Parkinson-like symptoms (a list of these drugs is provided).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to manage Parkinson's disease using remote monitoring technology. It aims to help you and your doctor keep track of your symptoms and adjust your care from home, improving your quality of life.
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This study tests how well remote monitoring tools, like wearable devices, can track symptoms in people with movement disorders like PSP, Parkinson's disease, or MSA. The goal is to see if these tools can help doctors better understand how the disease progresses from home.
This trial looks at how analyzing hand movements might help doctors tell the difference between Parkinson's disease and other similar conditions early on. It may help improve diagnosis so patients get the right care sooner.
This study uses artificial intelligence to analyze videos of standard motor tests (MDS-UPDRS Part III) for people with Parkinson's disease. It aims to see if AI can reliably assess your symptoms, which could lead to easier, more accessible monitoring in the future.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.